Gachon University Gil Medical Center

πŸ‡°πŸ‡·South Korea
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.gilhospital.com
Clinical Trials
Related News

Second-Line Irinotecan vs. ILF for AGC

First Posted Date
2007-08-01
Last Posted Date
2007-08-01
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
50
Registration Number
NCT00509964
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

Topotecan for Irinotecan-Refractory SCLC

First Posted Date
2007-07-18
Last Posted Date
2008-03-12
Lead Sponsor
Gachon University Gil Medical Center
Registration Number
NCT00502762
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain

Phase 2
Completed
Conditions
Advanced Solid Cancers
First Posted Date
2007-05-24
Last Posted Date
2008-03-13
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
2006
Registration Number
NCT00478101

Safety and Effects of Ramipril Combined With Candesartan

Phase 4
Completed
Conditions
Hypertension
First Posted Date
2006-07-26
Last Posted Date
2006-07-26
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
40
Registration Number
NCT00356395

ILF With/Without Cisplatin for Advanced Gastric Cancer

Phase 2
Conditions
Stomach Neoplasm
First Posted Date
2006-05-03
Last Posted Date
2007-03-12
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
86
Registration Number
NCT00320294
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

Irinotecan Discontinuation and Reintroduction for Advanced Colorectal Cancer

Phase 2
Terminated
Conditions
Colorectal Neoplasms
Metastases
First Posted Date
2006-05-03
Last Posted Date
2008-11-25
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
72
Registration Number
NCT00320320
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLC

First Posted Date
2006-04-27
Last Posted Date
2008-03-12
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
50
Registration Number
NCT00319800
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC

Phase 2
Completed
Conditions
Advanced Non-Small Cell Lung Cancer
First Posted Date
2006-04-27
Last Posted Date
2008-03-12
Lead Sponsor
Gachon University Gil Medical Center
Target Recruit Count
78
Registration Number
NCT00319514
Locations
πŸ‡°πŸ‡·

Gachon University Gil Medical Center, Incheon, Korea, Republic of

Β© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy